The Handbook of Psychopharmacology Trials: An Overview of Scientific, Political, and Ethical Concerns Contributor(s): M. D., Marc Hertzman (Author) |
|
ISBN: 0814735320 ISBN-13: 9780814735329 Publisher: New York University Press OUR PRICE: $88.11 Product Type: Hardcover Published: June 1997 Annotation: Each year pharmaceutical companies invest billions of dollars in clinical trials of drugs used for the treatment of central nervous system diseases. Due to enormous progress in basic pharmaceutical research in recent years, controlled tests of new medications are flourishing and these trials have rapidly become an intense focus of practical medical research. Aware of the complexities presented in the design, execution, and evaluation of clinical trials, Marc Hertzman and Douglas E. Feltner bring together a collection of essays that dissect the scientific, psychosocial, political, and ethical concerns that must be examined for any CNS trial. The internationally known contributors examine concerns about ethics and cost; the FDA and its regulatory impact; and the implementation of a variety of trials, for disorders such as schizophrenia, alcoholism, eating disorders, insomnia, and aggression. The editors carefully consider important social issues including the considerations related to women's special needs; and the relative merits of psychotherapy and medications. The Handbook of Psychopharmocology Trials provides an up-to- date and stimulating exploration of important issues on the subject of CNS Clinical trials.
|
Additional Information |
BISAC Categories: - Medical | Pain Medicine - Medical | Psychiatry - Psychopharmacology - Psychology |
Dewey: 615.780 |
LCCN: 96045902 |
Physical Information: 1.19" H x 6" W x 9" (1.84 lbs) 454 pages |
Themes: - Ethnic Orientation - African American - Chronological Period - 18th Century |
Descriptions, Reviews, Etc. |
Publisher Description: Each year pharmaceutical companies invest billions of dollars in clinical trials of drugs used for the treatment of central nervous system diseases. Due to enormous progress in basic pharmaceutical research in recent years, controlled tests of new medications are flourishing and these trials have rapidly become an intense focus of practical medical research. |
Contributor Bio(s): Hertzman M. D., Marc: - Marc Hertzman is Clinical Professor of Psychiatry at the University of Maryland, and Medical Director of Psychiatry at the North Arundel Hospital in Glen Burnie, Maryland. Douglas E. Feltner is a Howard Hughes Medical Institute postdoctoral Fellow at the National Institutes of Health, and Assistant Clinical Professor of Psychiatry at George Washington University. |